# EndoPAT Device for Endothelial Dysfunction in ED

> **NCT06720597** · NA · RECRUITING · sponsor: **University of California, Irvine** · enrollment: 120 (estimated)

## Conditions studied

- Erectile Dysfunction
- Hypogonadism, Male
- Endothelial Dysfunction

## Interventions

- **DRUG:** Daily low-dose PDE5 inhibitor therapy
- **DRUG:** Testosterone therapy as per clinical guidelines.

## Key facts

- **NCT ID:** NCT06720597
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-13
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06720597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06720597, "EndoPAT Device for Endothelial Dysfunction in ED". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06720597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*